Diversified Trust Co Purchases Shares of 4,685 Masimo Corporation $MASI

Diversified Trust Co purchased a new position in shares of Masimo Corporation (NASDAQ:MASI) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 4,685 shares of the medical equipment provider’s stock, valued at approximately $833,000.

Other large investors also recently modified their holdings of the company. Corient Private Wealth LLC boosted its stake in Masimo by 1.2% during the fourth quarter. Corient Private Wealth LLC now owns 340,230 shares of the medical equipment provider’s stock worth $44,250,000 after acquiring an additional 4,015 shares in the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in Masimo in the fourth quarter valued at $116,000. Pacer Advisors Inc. increased its stake in Masimo by 21.1% in the fourth quarter. Pacer Advisors Inc. now owns 7,360 shares of the medical equipment provider’s stock valued at $957,000 after purchasing an additional 1,280 shares in the last quarter. Virtu Financial LLC acquired a new position in shares of Masimo during the fourth quarter valued at about $258,000. Finally, T. Rowe Price Investment Management Inc. raised its holdings in shares of Masimo by 9.6% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,330,158 shares of the medical equipment provider’s stock valued at $303,061,000 after purchasing an additional 203,395 shares during the period. Institutional investors and hedge funds own 85.96% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Weiss Ratings upgraded Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. Wells Fargo & Company raised Masimo to a “hold” rating in a research note on Wednesday, March 18th. Finally, Raymond James Financial downgraded Masimo from an “outperform” rating to a “market perform” rating in a research note on Friday, March 27th. Nine equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $180.40.

Masimo Stock Performance

Shares of MASI stock opened at $179.95 on Thursday. The firm has a market capitalization of $9.42 billion, a PE ratio of -17.07, a price-to-earnings-growth ratio of 1.82 and a beta of 1.11. The firm has a fifty day simple moving average of $178.93 and a two-hundred day simple moving average of $162.74. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56. Masimo Corporation has a 12 month low of $125.94 and a 12 month high of $179.99.

Masimo Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.